These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22120538)

  • 1. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency.
    Kimber I; Maxwell G; Gilmour N; Dearman RJ; Friedmann PS; Martin SF
    Toxicology; 2012 Jan; 291(1-3):18-24. PubMed ID: 22120538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A future approach to measuring relative skin sensitising potency: a proposal.
    Jowsey IR; Basketter DA; Westmoreland C; Kimber I
    J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
    Kimber I; Pemberton MA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro approaches to the identification and characterization of skin sensitizers.
    Basketter D; Maxwell G
    Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of contact allergens according to potency: proposals.
    Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
    Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo analysis of pro- and anti-inflammatory effects of weak and strong contact allergens.
    Lass C; Merfort I; Martin SF
    Exp Dermatol; 2010 Nov; 19(11):1007-13. PubMed ID: 20701630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and adaptive immune responses in contact dermatitis: analogy with infections.
    Freudenberg MA; Esser PR; Jakob T; Galanos C; Martin SF
    G Ital Dermatol Venereol; 2009 Apr; 144(2):173-85. PubMed ID: 19357624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphocyte transformation test in allergic contact dermatitis: New opportunities.
    Popple A; Williams J; Maxwell G; Gellatly N; Dearman RJ; Kimber I
    J Immunotoxicol; 2016; 13(1):84-91. PubMed ID: 25655136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
    Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis.
    Kimber I; Basketter DA; Gerberick GF; Dearman RJ
    Int Immunopharmacol; 2002 Feb; 2(2-3):201-11. PubMed ID: 11811925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin sensitization: strategies for the assessment and management of risk.
    Basketter DA
    Br J Dermatol; 2008 Aug; 159(2):267-73. PubMed ID: 18503602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resolution of allergic contact dermatitis.
    Gaspari AA
    Am J Contact Dermat; 1996 Dec; 7(4):212-9. PubMed ID: 8955483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin sensitization: understanding the in vivo situation for the development of reliable in vitro test approaches.
    Aeby P; Python F; Goebel C
    ALTEX; 2007; 24 Spec No():3-5. PubMed ID: 19835043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
    Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
    ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
    Roberts DW; Api AM; Safford RJ; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo testing techniques for allergic contact dermatitis.
    Gerberick GF; Sikorski EE
    Am J Contact Dermat; 1998 Jun; 9(2):111-8. PubMed ID: 9601899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.